Pharmaceutical manufacturers of Iohexol

At GE HealthCare, we see possibilities through innovation. We’re partnering with our customers to fulfill healthcare’s greatest potential through groundbreaking medical technology, intelligent devices, and care solutions. Better tools enabling better patient care. Together, we are not only building a healthier future but living our purpose to create a world where healthcare has no limits.

Global Calcium is a prominent enterprise operating globally, specializing in the advancement, creation, manufacturing, and endorsement of natural mineral salts. Currently, the enterprise holds the top position worldwide in various product categories, including elaborate active pharmaceutical ingredients, mineral salts such as Gluconates, Lactates, Lactobionates, citrates, Orotates, Pidolates, Levulinates, and amino acid derivatives, among others. Headquartered in Bangalore, India, the company integrates cutting-edge technology and provides products that conform to the highest quality standards.

Hovione brings over six decades of experience as a CDMO and serves as a specialized integrated provider delivering solutions for drug substance, drug product intermediate, and drug product. With four FDA examined facilities in the United States, China, Ireland, and Portugal, as well as research laboratories in Portugal and the United States, the company supplies pharmaceutical customers with services for the development and compliant production of innovative drugs, including highly potent compounds. Hovione delivers a comprehensive range of development services and manufacturing capabilities in particle engineering such as Spray Drying.

Korea Otsuka Pharmaceutical represents the Korean branch of the esteemed global pharmaceutical firm Otsuka Pharmaceutical. Despite being a division of a multinational pharmaceutical corporation, Korea Otsuka Pharmaceutical has established an independent operational base in South Korea and has contributed to the advancement of the pharmaceutical industry in Korea by reinvesting the earnings from pharmaceutical product sales into production equipment and clinical research.

Established in 2008 in the Republic of Korea, MFC is a rapidly expanding pharmaceutical company that specializes in pharmaceutical research and development, APIs, pharmaceutical intermediates, Pd catalysts, and custom manufacturing services. MFC consistently prioritizes the quality of its products, ensuring that all production processes adhere to GMP standards. The company maintains independent QA & QC to effectively uphold the execution and operation of the GMP Quality system.

Brother Enterprises Holding Co., Ltd. was established in 1991, with its main office situated in Haining City, Zhejiang Province

Justesa Imagen specializes in producing APIs and intermediates for the global pharmaceutical and animal health sectors. With close to a century of expertise, our operational approach is rooted in a blend of top-notch manufacturing infrastructure and a proven history of dependable service. Our facilities adhere to cGMP standards and have undergone thorough inspections to ensure the highest quality.

Established in 2006, Zhejiang Hichi Pharmaceutical Corporation Limited is situated in Taizhou City, Zhejiang Province, which is recognized as the most vibrant hub for chemical API production in southeastern China. The company is dedicated to the advancement of various APIs such as X-CT non-ionic iodine contrast agents, MRI contrast agents, cardiovascular, hypoglycemic, and more. Hichi Pharma, a national high-tech enterprise, boasts a youthful and professional R&D team, advanced manufacturing and testing facilities, and impeccable infrastructure. Its newly developed products and technologies have garnered national, provincial, and municipal accolades consecutively.